Pulmonary Drug Delivery Systems Market Size, Share & Trends Report

Pulmonary Drug Delivery Systems Market Size, Share & Trends Analysis Report By Product (Inhalers, Nebulizers, Accessories), By Application (Asthma, Cystic Fibrosis), By End-use, By Region And Segment Forecasts, 2024 - 2030

Report ID: GVR-1-68038-587-8
Number of Report Pages: 100
Format: PDF, Horizon Databook

Historical Range: 2018 - 2022
Forecast Period: 2024 - 2030
Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Pulmonary Drug Delivery Systems Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Pulmonary Drug Delivery Systems Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Pulmonary Drug Delivery Systems Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Pulmonary Drug Delivery Systems Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Inhalers
4.3.1. Inhalers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Nebulizers
4.4.1. Nebulizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Accessories
4.5.1. Accessories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Pulmonary Drug Delivery Systems Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Pulmonary Drug Delivery Systems Market: Application Movement Analysis, 2023 & 2030 (USD Million)
5.3. Asthma
5.3.1. Asthma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Cystic Fibrosis
5.4.1. Cystic Fibrosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Chronic Obstructive Pulmonary Disease (COPD)
5.5.1. Chronic Obstructive Pulmonary Disease (COPD) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Allergic Rhinitis
5.6.1. Allergic Rhinitis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Pulmonary Arterial Hypertension
5.7.1. Pulmonary Arterial Hypertension Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Others
5.8.1. Other Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Pulmonary Drug Delivery Systems Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Pulmonary Drug Delivery Systems Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
6.3. Hospitals & Clinics
6.3.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Ambulatory Surgical Centers (ASCs)
6.4.1. Ambulatory Surgical Centers (ASCs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Home Care
6.5.1. Home Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Others
6.6.1. Other End Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Pulmonary Drug Delivery Systems Market: Regional Estimates & Trend Analysis
7.1. Pulmonary Drug Delivery Systems Market Share, By Region, 2023 & 2030, USD Million
7.2. North America
7.2.1. North America Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. France Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Italy Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Spain Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Denmark Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Sweden Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Norway Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. China
7.4.2.1. China Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Japan Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. South Korea Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Australia Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Thailand Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Argentina Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Saudi Arabia
7.6.2.1. Saudi Arabia Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. UAE
7.6.3.1. UAE Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. South Africa
7.6.4.1. South Africa Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Kuwait Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. 3M
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. AstraZeneca
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. GSK plc.
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Novartis AG
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Koninklijke Philips N.V.
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Boehringer Ingelheim International GmbH.
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. Teva Pharmaceutical Industries Ltd.
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. OMRON Healthcare, Inc.
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. PARI GmbH
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. Cipla
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.